These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35046831)

  • 1. Sex Hormone-Dependent Lipid Mediator Formation in Male and Female Mice During Peritonitis.
    Troisi F; Pace S; Jordan PM; Meyer KPL; Bilancia R; Ialenti A; Borrelli F; Rossi A; Sautebin L; Serhan CN; Werz O
    Front Pharmacol; 2021; 12():818544. PubMed ID: 35046831
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators.
    Pace S; Zhang K; Jordan PM; Bilancia R; Wang W; Börner F; Hofstetter RK; Potenza M; Kretzer C; Gerstmeier J; Fischer D; Lorkowski S; Gilbert NC; Newcomer ME; Rossi A; Chen X; Werz O
    Pharmacol Res; 2021 May; 167():105556. PubMed ID: 33812006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201.
    Kretzer C; Jordan PM; Bilancia R; Rossi A; Gür Maz T; Banoglu E; Schubert US; Werz O
    J Inflamm Res; 2022; 15():911-925. PubMed ID: 35173459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization.
    Zhang K; Jordan PM; Pace S; Hofstetter RK; Werner M; Chen X; Werz O
    J Inflamm Res; 2022; 15():3285-3304. PubMed ID: 35676971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages.
    Kretzer C; Jordan PM; Meyer KPL; Hoff D; Werner M; Hofstetter RK; Koeberle A; Cala Peralta A; Viault G; Seraphin D; Richomme P; Helesbeux JJ; Stuppner H; Temml V; Schuster D; Werz O
    Biochem Pharmacol; 2022 Jan; 195():114825. PubMed ID: 34762841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial Modulation of Lipid Mediator Biosynthesis in Innate Immune Cells by Antirheumatic
    Zhang K; Pace S; Jordan PM; Peltner LK; Weber A; Fischer D; Hofstetter RK; Chen X; Werz O
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067705
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis.
    Rossi A; Pergola C; Pace S; Rådmark O; Werz O; Sautebin L
    Pharmacol Res; 2014 Sep; 87():1-7. PubMed ID: 24892983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus controls eicosanoid and specialized pro-resolving mediator production via lipoteichoic acid.
    Miek L; Jordan PM; Günther K; Pace S; Beyer T; Kowalak D; Hoerr V; Löffler B; Tuchscherr L; Serhan CN; Gerstmeier J; Werz O
    Immunology; 2022 May; 166(1):47-67. PubMed ID: 35143048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Androgens on Inflammation-Related Lipid Mediator Biosynthesis in Innate Immune Cells.
    Pace S; Werz O
    Front Immunol; 2020; 11():1356. PubMed ID: 32714332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: A promising pharmacological strategy for anti-inflammatory therapy.
    Gerstmeier J; Kretzer C; Di Micco S; Miek L; Butschek H; Cantone V; Bilancia R; Rizza R; Troisi F; Cardullo N; Tringali C; Ialenti A; Rossi A; Bifulco G; Werz O; Pace S
    Biochem Pharmacol; 2019 Jul; 165():263-274. PubMed ID: 30836057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
    Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
    Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgolic Acid is a Multi-Target Inhibitor of Key Enzymes in Pro-Inflammatory Lipid Mediator Biosynthesis.
    Gerstmeier J; Seegers J; Witt F; Waltenberger B; Temml V; Rollinger JM; Stuppner H; Koeberle A; Schuster D; Werz O
    Front Pharmacol; 2019; 10():797. PubMed ID: 31379572
    [No Abstract]   [Full Text] [Related]  

  • 13. Allosteric Activation of 15-Lipoxygenase-1 by Boswellic Acid Induces the Lipid Mediator Class Switch to Promote Resolution of Inflammation.
    Börner F; Pace S; Jordan PM; Gerstmeier J; Gomez M; Rossi A; Gilbert NC; Newcomer ME; Werz O
    Adv Sci (Weinh); 2023 Feb; 10(6):e2205604. PubMed ID: 36567268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome.
    Werner M; Jordan PM; Romp E; Czapka A; Rao Z; Kretzer C; Koeberle A; Garscha U; Pace S; Claesson HE; Serhan CN; Werz O; Gerstmeier J
    FASEB J; 2019 May; 33(5):6140-6153. PubMed ID: 30735438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity.
    Cai B; Kasikara C; Doran AC; Ramakrishnan R; Birge RB; Tabas I
    Sci Signal; 2018 Sep; 11(549):. PubMed ID: 30254055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Natural Combination Medicine Traumeel (Tr14) Improves Resolution of Inflammation by Promoting the Biosynthesis of Specialized Pro-Resolving Mediators.
    Jordan PM; van Goethem E; Müller AM; Hemmer K; Gavioli V; Baillif V; Burmeister Y; Krömmelbein N; Dubourdeau M; Seilheimer B; Werz O
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing.
    Halade GV; Kain V; Ingle KA; Prabhu SD
    Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H89-H102. PubMed ID: 28411230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP).
    Pergola C; Gerstmeier J; Mönch B; Çalışkan B; Luderer S; Weinigel C; Barz D; Maczewsky J; Pace S; Rossi A; Sautebin L; Banoglu E; Werz O
    Br J Pharmacol; 2014 Jun; 171(12):3051-64. PubMed ID: 24641614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans.
    Jónasdóttir HS; Brouwers H; Kwekkeboom JC; van der Linden HMJ; Huizinga T; Kloppenburg M; Toes REM; Giera M; Ioan-Facsinay A
    Osteoarthritis Cartilage; 2017 Jul; 25(7):1150-1160. PubMed ID: 28189826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E
    Cheung SY; Werner M; Esposito L; Troisi F; Cantone V; Liening S; König S; Gerstmeier J; Koeberle A; Bilancia R; Rizza R; Rossi A; Roviezzo F; Temml V; Schuster D; Stuppner H; Schubert-Zsilavecz M; Werz O; Hanke T; Pace S
    Eur J Med Chem; 2018 Aug; 156():815-830. PubMed ID: 30053720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.